Acta Scientific Veterinary Sciences (ISSN: 2582-3183)

Research Article Volume 7 Issue 2

CRISPR-Cas9 Mediated Paraflagellar rod 1 Gene Editing in Trypanosoma Evansi

S Anandu1, Basavaraj Sajjanar2, Vijayakumar Jawalagatti3, Laharika Reddy1, Yashica KA1, Saravanan BC4 and Anup Kumar Tewari1*

1Division of Parasitology, ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, India
2Division of Animal Biotechnology, ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, India
3Mayo Clinic, Rochester, United States
4CADRAD, ICAR- ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, India

*Corresponding Author: Anup Kumar Tewari, Division of Parasitology, ICAR-Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, India.

Received: November 26, 2024; ; Published: January 31, 2025

Abstract

Trypanosoma evansi, a blood protozoan parasite of high economic importance, has a wide prevalence in the vertebrates in many tropical countries including India. The parasite is transmitted by the hematophagous flies and causes a chronic debilitating disease ‘Surra’ in domestic livestock. Development of a protective vaccine has not yet been possible due to the ability of the parasite to evade the host's immune response by periodically changing its surface glycoproteins. The Paraflagellar Rod 1 (PFR1) gene codes for a major flagellar constituent PFR1 protein of T. evansi. We report here a specifically targeted editing of the T. evansi PFR1 gene by the CRISPR Cas9 tool. We combined the single guide RNA (sgRNA) and recombinant Cas9 protein in-vitro to form a ribonucleoprotein complex (RNP) for transfecting T. evansi and the induced mutation in the coding sequence of PFR1 was assessed by T7E1 endonuclease assay. The CRISPR-Cas9-mediated PFR1 gene-edited parasites had a significantly shorter lifespan in vitro.

 Keywords: Trypanosoma Evansi; PFR1; CRISPR; Cas9; Gene Editing

References

    <
  1. Dobson RJ., et al. “Models for Trypanosoma evansi (surra), its control and economic impact on small-hold livestock owners in the Philippines”. International Journal of Parasitology 39 (2009): 1115-1123.
  2. Aregawi Weldegebrial G., et al. “Systematic review and meta-analysis on the global distribution, host range, and prevalence of Trypanosoma evansi”. Parasites and Vectors12 (2019): 1-25.
  3. Singh, Harkirat., et al. “Seroprevalence of babesiosis in cattle and buffaloes by indirect fluorescent antibody test”. Journal of Veterinary Parasitology1 (2007): 1-4.
  4. Kundu Krishnendu., et al. “Sero-surveillance for surra in cattle using native surface glycoprotein antigen from Trypanosoma evansi”. Veterinary Parasitology3-4 (2013): 258-264.
  5. Hoare Cecil A. "Morphological and taxonomic studies on mammalian trypanosomes. X. Revision of the systematics”. The Journal of Protozoology2 (1964): 200-207.
  6. Raina AK., et al. “Oral transmission of Trypanosoma evansi infection in dogs and mice”. Veterinary Parasitology1 (1985): 67-69.
  7. Desquesnes M., et al. “Trypanosoma evansi and surra: a review and perspectives on origin, history, distribution, taxonomy, morphology, hosts, and pathogenic effects”. Biomed Research International (2013): 194176.
  8. Sudhakar NR., et al. “Seroprevalence of Trypanosoma evansi in cattle of Karnataka”. Indian Journal of Veterinary Medicine2 (2014): 106-110.
  9. Sudan, Vikrant AK Tewari and Harkirat Singh. "A native whole cell lysate antigen (WCLA) based ELISA for the sero-detection of surra in Indian cattle”. The Indian Journal of Animal Sciences6 (2015): 601-603.
  10. Holland WG., et al. “The effect of Trypanosoma evansi infection on pig performance and vaccination against classical swine fever”. Veterinary Parasitology2-3 (2003): 115-123.
  11. Namangala Boniface and Steven Odongo. "Animal African trypanosomosis in sub-Saharan Africa and beyond African borders”. Trypanosomes and trypanosomiasis. Vienna: Springer Vienna, 2013. 239-260.
  12. OIE (World Organization for Animal Health). OIE Listed diseases, infections and infestations in force in (2018).
  13. Kundu K., et al. “Existence of genetic variability among Indian isolates of Trypanosoma evansi”. The Indian Journal of Animal Sciences 1 (2010): 3-6.
  14. Tewari, Anup Kumar., et al. “Protective antibody and cytokine responses in mice following immunization with recombinant beta-tubulin and subsequent Trypanosoma evansi challenge”. Parasites and Vectors8 (2015): 1-8.
  15. Jawalagatti V., et al. “Expression kinetics of cytokines and the humoral antibody response concerning short-term protection induced by radiation-attenuated Trypanosoma evansi in bovine calves”. Vaccine 41 (2023): 1668-1678.
  16. Deflorin Judith., et al. “The major components of the paraflagellar rod of Trypanosoma brucei are two similar, but distinct proteins which are encoded by two different gene loci”. Journal of Biological Chemistry46 (1994): 28745-28751.
  17. Maharana BR., et al. “Isolation and characterization of paraflagellar rod protein gene (Pfr1) in Trypanosoma evansi and its conservation among other kinetoplastid parasites”. Indian Journal of Animal Research4 (2011b): 283-288.
  18. Maharana BR., et al. “Cloning and expression of paraflagellar ROD protein 2 (PFR2) gene of Trypanosoma evansi”. Journal of Veterinary Parasitology2 (2011a): 118-123.
  19. Maharana Biswa Ranjan., et al. “Evaluation of the immunoprotective potential of recombinant paraflagellar rod proteins of Trypanosoma evansi in mice”. Vaccines1 (2020): 84. .
  20. Maharana BR., et al. “Molecular characterization of paraflagellar rod protein gene (PFR) of Trypanosoma evansi”. Journal of Applied Animal Research1 (2014): 1-5.
  21. Maharana BR., et al. “An overview on kinetoplastid paraflagellar rod”. Journal of Parasitic Diseases39 (2015): 589-595.
  22. Hunger-Glaser., et al. “Deletion of the genes for the paraflagellar rod protein PFR-A in Trypanosoma brucei is probably lethal”. Molecular and Biochemical Parasitology (1997): 347-351.
  23. Bastin Philippe., et al. “Paraflagellar rod is vital for trypanosome motility”. Nature6667 (1998): 548-548.
  24. Abdille MdH., et al. “Evidence for the existence of paraflagellar rod protein 2 (PFR2) gene in Trypanosoma evansi and its conservation among other kinetoplastid parasites”. Experimental Parasitology4 (2008): 614-618.
  25. Lander Noelia., et al. “Calcium-sensitive pyruvate dehydrogenase phosphatase is required for energy metabolism, growth, differentiation, and infectivity of Trypanosoma cruzi”. Journal of Biological Chemistry45 (2018): 17402-17417.
  26. Hakimi Hassan., et al. “Genome editing of Babesia bovis using the CRISPR/Cas9 system”. MSphere3 (2019): 10-1128.
  27. Rico Eva., et al. “Inducible high-efficiency CRISPR-Cas9-targeted gene editing and precision base editing in African trypanosomes”. Scientific Reports1 (2018): 7960.
  28. Lander Noelia., et al. “CRISPR/Cas9-induced disruption of paraflagellar rod protein 1 and 2 genes in Trypanosoma cruzi reveals their role in flagellar attachment”. MBio4 (2015): 10-1128.
  29. Bryant Naomi. "Endogenous Gene Tagging of pfr2 and pfr5 in Trypanosoma cruzi Using CRISPR/Cas9”. Biology, Medicine (2019).
  30. Sollelis Lauriane., et al. “First efficient CRISPR‐C as9‐mediated genome editing in Leishmania parasites”. Cellular Microbiology10 (2015): 1405-1412.
  31. Lanham Sheila M and DG Godfrey. "Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose”. Experimental Parasitology3 (1970): 521-534.
  32. Lumsden WH. “Techniques with trypanosomes. Edinburgh and London”. Churchill Livingstone Publishers 183 (1973).
  33. Cross GAM and JC Manning. "Cultivation of Trypanosoma brucei sspp. in semi-defined and defined media”. Parasitology3 (1973): 315-331.
  34. Srivastava RVN., et al. “Separation of Trypanosoma evansi through diethyl amino ethyl cellulose columns”. Journal of Veterinary Parasitology (1988): 67-69.
  35. Hirumi H and K Hirumi. "In vitro cultivation of Trypanosoma congolense bloodstream forms in the absence of feeder cell layers”. Parasitology2 (1991): 225-236.
  36. Hirumi H., et al. “African trypanosomes: cultivation of animal-infective Trypanosoma brucei in vitro”. Science4293 (1977): 992-994.
  37. Kolev Nikolay G., et al. “RNA interference in protozoan parasites: achievements and challenges”. Eukaryotic Cell9 (2011): 1156-1163.
  38. Alsford Sam., et al. “High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome”. Genome Research6 (2011): 915-924.
  39. Peng Duo and Rick Tarleton. "EuPaGDT: a web tool tailored to design CRISPR guide RNAs for eukaryotic pathogens”. Microbial Genomics4 (2015): e000033.
  40. Lander Noelia., et al. “Genome editing by CRISPR/Cas9: a game change in the genetic manipulation of protists”. Journal of Eukaryotic Microbiology5 (2016): 679-690.
  41. Zhang Wen-Wei and Greg Matlashewski. "CRISPR-Cas9-mediated genome editing in Leishmania donovani”. MBio4 (2015): 10-1128.
  42. Glover Lucy., et al. “Sequence homology and microhomology dominate chromosomal double-strand break repair in African trypanosomes”. Nucleic Acids Research8 (2008): 2608-2618.
  43. Doudna Jennifer A and Emmanuelle Charpentier. "The new frontier of genome engineering with CRISPR-Cas9”. Science6213 (2014): 1258096.
  44. Zhang Wen-Wei., et al. “Optimized CRISPR-Cas9 genome editing for Leishmania and its use to target a multigene family, induce chromosomal translocation, and study DNA break repair mechanisms”. MSphere1 (2017): 10-1128.
  45. Docampo Roberto. "Molecular parasitology in the 21st century”. Essays in Biochemistry51 (2011): 1-13.
  46. Aurrecoechea Cristina., et al. “EuPathDB: the eukaryotic pathogen genomics database resource”. Nucleic Acids ResearchD1 (2017): D581-D591.
  47. Heler Robert., et al. “Cas9 specifies functional viral targets during CRISPR-Cas adaptation”. Nature7542 (2015): 199-202.

Citation

Citation: Anup Kumar Tewari., et al. “CRISPR-Cas9 Mediated Paraflagellar rod 1 Gene Editing in Trypanosoma Evansi". Acta Scientific Veterinary Sciences 7.2 (2025): 33-39.

Copyright

Copyright: © 2025 Anup Kumar Tewari., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.008

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.

Contact US